![]() | Study programme 2025-2026 | Français | |
![]() | Neuropharmacology | ||
Programme component of Master's in Biomedical Sciences (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M1-BIOMED-022-M | Optional UE | COLOMAR Aurore | M119 - Neurosciences |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Anglais | 30 | 0 | 0 | 0 | 0 | 4 | 4.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-NEUR-026 | Neuropharmacology | 30 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
cf AA desccription
UE Content: description and pedagogical relevance
cf AA description
Prior Experience
Not applicable
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-NEUR-026 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-NEUR-026 |
|
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-NEUR-026 | Slides of the course available in French & in English on Moodle |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-NEUR-026 | Sans objet |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-NEUR-026 | Molecular Neuropharmacology, third Edition. (2015) Nestler et al. Mc Graw Hill Education. Stahl's essential psychopharmacology (2013) Stahl & Muntner. Cambridge University Press Medecine. Goodman & Gilman Pharmacological basis of therapeutics, 12th Edition. (2011) Brunton et al. Mc Graw Hill Books. |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-NEUR-026 | Authorized |
Term 1 Assessment - type
| AA | Type(s) and mode(s) of Q1 assessment |
|---|---|
| M-NEUR-026 |
|
Term 1 Assessment - comments
| AA | Term 1 Assessment - comments |
|---|---|
| M-NEUR-026 | The evaluation will consist in knowledge questions about neuropharmacology concepts and open questions about experimental results of neuropharmacologicela research. A quote corresponding to your participation in class can be added to the quote of the written exam. The final exam is given in English. |
Resit Assessment - Term 1 (BAB1) - type
| AA | Type(s) and mode(s) of Q1 resit assessment (BAB1) |
|---|---|
| M-NEUR-026 |
|
Resit Assessment - Term 1 (BAB1) - Comments
| AA | Resit Assessment - Term 1 (BAB1) - Comments |
|---|---|
| M-NEUR-026 | Not applicable |
Term 3 Assessment - type
| AA | Type(s) and mode(s) of Q3 assessment |
|---|---|
| M-NEUR-026 |
|
Term 3 Assessment - comments
| AA | Term 3 Assessment - comments |
|---|---|
| M-NEUR-026 | Same as in Q1 |